Oral Answers to Questions Debate

Full Debate: Read Full Debate
Department: Cabinet Office

Oral Answers to Questions

Gregor Poynton Excerpts
Wednesday 12th February 2025

(1 month, 1 week ago)

Commons Chamber
Read Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
Peter Kyle Portrait Peter Kyle
- View Speech - Hansard - - - Excerpts

Obviously, I cannot comment on the CMA, which is an independent regulator. I can, however, say that this Government, via the AI opportunities action plan, have committed to fully investing in AI infrastructure so that we can have a sovereign AI infrastructure here, with data stored here and processed here, creating jobs and wealth in this country.

Gregor Poynton Portrait Gregor Poynton (Livingston) (Lab)
- Hansard - -

2. What steps his Department is taking to support innovation in Livingston constituency.

Chris Bryant Portrait The Minister for Data Protection and Telecoms (Chris Bryant)
- View Speech - Hansard - - - Excerpts

We have already spent £4 million on projects in my hon. Friend’s constituency, including £88,000 on SilviBio Ltd. I am very proud of the fact that we have been able to commit, in 2025-26, to a record amount of money—£20.4 billion—for research and development.

Gregor Poynton Portrait Gregor Poynton
- View Speech - Hansard - -

I thank the Minister for that answer. In the Livingston constituency, we have a number of fantastic biotech and life sciences businesses, such as Valneva, which is working on a range of vaccines, including for malaria, and as the Minister mentioned, SilviBio, which is working on sustainable alternatives to peat. Given the failure and neglect of the Conservative Government and the SNP Scottish Government in this regard, what conversations is he having with the Scottish Government to ensure that we create an environment in which the biotech and life sciences industry can thrive in the Livingston constituency and across Scotland?

Chris Bryant Portrait Chris Bryant
- View Speech - Hansard - - - Excerpts

Livingston is a remarkable example of where investment can make a significant difference. I am really pleased that the chief executive of SilviBio recently received a women in innovation award for innovation in science. My hon. Friend is absolutely right that innovation accelerator projects in Glasgow and across the whole of Scotland need the integration between the Westminster Government and the Holyrood Government to be really successful, but that is precisely what we are determined to do. In October last year, he also had another £4 million investment in Livingston by Merck, making it one of the biggest investors in Scotland.